Skip to content

Author

L. Zhukova

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Search for prognostic factors when prescribing immunotherapy in the second line of treatment for metastatic gastric cancer

The results obtained leave a reasonable assumption that a group of patients on the 1st line had PFS > 8 months and a normal baseline LDH level, and they had real benefits from ICI therapy with the 2nd line therapy for metastatic gastric cancer.

N. N. Semenov, M. Fedyanin, L. Zhukova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.